Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|ICT01||ICT-01|ICT 01||ICT01 is an agonistic monoclonal antibody that targets BTN3A, which leads to activation of Vgamma9Vdelta2 T lymphocytes, potentially resulting in tumor cell killing, delayed tumor growth, and enhanced antitumor immune response (PMID: 34669444).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04243499||Phase I||ICT01||First-in-Human Study of ICT01 in Patients With Advanced Cancer (EVICTION)||Recruiting||USA | GBR | FRA | ESP | DEU | BEL||0|